Biosensory Insect Control Corporation – Trademark Portfolio
Entity Type: 03
Biosensory Insect Control Corporation holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MOSQUITO 'COGNITO. The owner is based in Groton, CT.
Groton Business Park
Groton, CT 06340
Showing of trademarks Trademarks
Trademark Classifications
Biosensory Insect Control Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Biosensory Insect Control Corporation have?
Biosensory Insect Control Corporation has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.
What trademark classes does Biosensory Insect Control Corporation file in?
Biosensory Insect Control Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 5 (Pharmaceuticals). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.
What are Biosensory Insect Control Corporation's most well-known trademarks?
Biosensory Insect Control Corporation's registered trademark portfolio includes well-known marks such as MOSQUITO 'COGNITO. These are among 1 currently registered trademark in the portfolio.
What is Biosensory Insect Control Corporation's trademark registration success rate?
Biosensory Insect Control Corporation has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.